Abstract
Herein, we present a fluorescent-peptide drug delivery system composed of biotin–naphthalimide–HJ inhibitor peptide2, prodrug 1. Treatment of 1 to biotin receptor-positive HepG2 cells, which are resistant to high concentrations of the HJ inhibitor peptide2, decreased cell viability and increased intracellular fluorescence.
Original language | English |
---|---|
Pages (from-to) | 7690-7693 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 50 |
Issue number | 57 |
DOIs | |
Publication status | Published - 2014 Jun 19 |
ASJC Scopus subject areas
- Electronic, Optical and Magnetic Materials
- Ceramics and Composites
- Metals and Alloys
- Materials Chemistry
- Surfaces, Coatings and Films
- Chemistry(all)
- Catalysis